Ampersand captures the patient journey in high resolution, connecting the dots between episodes of care.
We support retrospective and prospective research using longitudinal patient-reported outcomes, digital biomarkers, point-of-care tests and behavioural and psychosocial data to build a richer picture of how inflammatory disease is experienced over time.
A richer picture of the patient journey
Our apps support people with long-term inflammatory conditions in everyday life. This ongoing engagement generates deep longitudinal data across symptoms, treatment, behaviour, wellbeing and physiology.
Patient-Reported Outcomes
Validated patient-reported outcomes and symptom tracking capture disease activity, fatigue, pain, mood, function and quality of life over time.
Biomarkers and Physiology
Wearables and point-of-care tests add objective measures including activity, sleep, resting heart rate, heart-rate variability, blood pressure, oxygen saturation and faecal calprotectin.
Treatment Data
Medication and treatment histories show what patients take, when treatment changes, and how their experience evolves before and after key treatment decisions.
Lifestyle and Behaviour
Sleep, activity, diet, stress and self-management data help reveal how everyday behaviours and circumstances interact with symptoms and disease activity.
Clinical Validation & Enrichment
NHS hospital partners use our clinical platform for research or routine care, adding clinically validated data points such as disease type, medication history, and clinical interactions.
Patient Experience
Surveys, qualitative feedback and digital engagement data add context around patient priorities, treatment experience, behaviour and unmet need.
Working together to understand the patient journey
We work with researchers, CROs and pharmaceutical companies to understand lived experience and outcomes across the patient journey, including around key treatment decisions.
Researchers
We support academic research using longitudinal patient data, helping teams explore disease burden, patient journeys and outcomes, test hypotheses and develop evidence for publication.
CROs
We work with CROs to add longitudinal patient-centred data, digital recruitment and prospective data collection to observational studies, clinical trials and broader evidence-generation programmes.
Pharmaceutical companies
We support pharmaceutical teams from Phase 2 through post-launch, helping characterise patient populations, understand treatment journeys, refine endpoints and generate evidence on outcomes in routine life.
Research & Evidence Capabilities
Ampersand combines an established longitudinal dataset with the ability to engage patients prospectively, allowing research questions to be answered retrospectively, prospectively or through both.
Observational research
Characterise real-world populations, disease burden, treatment patterns and outcomes using longitudinal patient-level data.
Longitudinal RWE studies
Follow symptoms, treatment, outcomes and behaviour over time to understand trajectories, transitions and key inflection points.
Patient insight research
Explore unmet need, lived experience and patient priorities using structured data, surveys and qualitative research.
Trial recruitment and participant engagement
Identify and engage relevant patient populations through established digital relationships, supporting recruitment, retention and ongoing study participation.
Outcomes research
Measure patient-centred outcomes in routine life, including symptoms, function, wellbeing, quality of life and treatment experience.
Endpoint selection
Use longitudinal trajectories to assess variability, missingness and sensitivity to change, helping teams select feasible, patient-centred endpoints for prospective studies.
With support from industry
We work with organisations across the healthcare and life sciences sector who share our commitment to improving support for people living with long-term conditions. With support from these organisations, we extend the reach of our patient programmes, develop valuable resources and help more people access practical, trusted support.
Research is underpinned by GDPR-compliant information governance, secure data handling and transparent patient consent. We use validated measures where appropriate, alongside proportionate quality assurance, ethical research practices and patient-centred study design.
Let's Explore What's Possible
Understanding the patient journey can lead to better research outcomes.
Talk to our research team about your evidence needs, the data available today and where prospective patient engagement could add another dimension.
